Page 65 - Portuguese Journal - SPORL - Vol 61. Nº2
P. 65

Figure 1
          Graph showing the symptoms reported by the patients on admission to the SU

























          remaining symptoms (cough, pharyngeal             MEWS on admission was 1.35, and the mode
          globus,  and  referred  otalgia)  was  lower  than   was 1 (35.3%). The MEWS distribution in the
          10.0% (Figure 1 ).                                remaining  patients  was  0  (27.5%),  2  (19.6%),
          The mean duration of the symptoms was             3 (9.8%), and 4 (7.8%), and the score did not
          three days (1–8 days), with 52.9% of the cases    exceed 4 in any patient (Figure 2).
          experiencing symptoms lasting for 48 hours        The mean length of hospital stay was seven
          or less. On admission to the SU, a purulent       days; however, the most frequent length was
          exudate was observed in the supraglottic          five  days,  varying  between  two  and  26  days.
          structures of 16 patients (31.4%). Elevation of   All patients received intravenous antibiotics,
          the inflammatory parameters was confirmed         with most being treated with ceftriaxone
          in most patients, with leukocytosis in 80.4%,     (78.4%), followed by clindamycin (29.3%). Dual
          neutrophilia in 76.5%, and elevated C-reactive    antibiotics and intravenous corticosteroids
          protein (CRP) in 94.1% of patients. Imaging       were  given to 58.8%  and  94.1% of  patients,
          examinations were requested (lateral X-ray        respectively (Table 2).
          and/or contrast computed tomography [CT]          Regarding    the   defined   outcomes,     the
          of the neck) for 35 patients (68.6%). The mean    frequency of epiglottic abscess (with or


          Figure 2
          Graph showing the distribution of the Modified Early Warning Score (MEWS)


























                                                                                      Volume 61 . Nº2 . June 2023 207
   60   61   62   63   64   65   66   67   68   69   70